Skip to main content

Table 1 Characteristics of severe malaria admissions during the study period

From: Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia

Characteristics

Malaria treatment

Intravenous artesunate and DHP (n = 7755)

Intravenous and oral quinine (n = 2759)

Age, median year (range)

12.9 (0.1–80.6)

16.0 (0.1–89.0)

Age group, n (%)

 0–< 1 years old

490 (6.3)

187 (6.8)

 1–< 5 years old

2103 (27.1)

683 (24.8)

 5–< 15 years old

1460 (18.8)

433 (15.7)

 ≥ 15 years old

3702 (47.7)

1456 (52.8)

Sex, n (%)

 Male

3871 (49.9)

1395 (50.6)

Pregnant women, n (%)

313 (4.0)

92 (3.3)

Ethnic group, n (%)

n = 7752

n = 2749

 Highland Papuan

5968 (77.0)

2233 (81.2)

 Lowland Papuan

682 (8.8)

260 (9.5)

 Non Papuan

1102 (14.2)

256 (9.3)

Species of malaria, n (%)

 P. falciparum

4960 (64.0)

1955 (70.9)

 P. vivax

1355 (17.5)

434 (15.7)

 Mixed

1373 (17.7)

356 (12.9)

 P. malariae

66 (0.9)

13 (0.5)

 P. ovale

1 (0.0)

1 (0.0)

Nutritional status, n (%)

 Normal

7696 (99.2)

2742 (99.4)

 Malnutrition

59 (0.8)

17 (0.6)

Haemoglobin

n = 7033

n = 2497

Hb, mean g/dl (95% CI)

8.9 (8.8–9.0)

7.9 (7.7–8.0)

Anaemia, n (%)

 Hb ≤ 5 g/dl

1180 (16.8)

591 (23.7)

 Hb > 5 g/dl

5853 (83.2)

1906 (76.3)